Position in GILD
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$1,781,267
-$206,846 QoQ
Shares Held
14,099
-1.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#868
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Mirador Capital Partners LP holds $28,463,151 across 9 Drug Manufacturers - General names. GILD ranks #5 (6.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
68,762 | $17,303,269 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
48,795 | $2,811,567 | |
| 3 | LLY |
ELI LILLY & Co
|
1,657 | $1,987,455 | |
| 4 | JNJ |
Johnson & Johnson
|
7,410 | $1,881,917 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
14,099 | $1,781,267 | |
| 6 | PFE |
Pfizer Inc
|
45,835 | $1,103,706 | |
| 7 | MRK |
Merck & Co., Inc.
|
5,882 | $755,837 | |
| 8 | AMGN |
Amgen Inc
|
1,410 | $510,589 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,781,267 | 14,099 | Shares | Sole | 2026-07-07 | |
| 2026-03-31 | $1,988,113 | 14,265 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $1,725,356 | 14,057 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $1,567,653 | 14,123 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $1,583,667 | 14,284 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $1,535,533 | 13,704 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $1,267,593 | 13,723 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $1,106,268 | 13,195 | Shares | Sole | 2024-10-04 | |
| 2024-06-30 | $874,914 | 12,752 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $878,780 | 11,997 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $902,775 | 11,144 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $779,376 | 10,400 | Shares | Sole | 2023-10-05 | |
| 2023-06-30 | $746,731 | 9,689 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $806,136 | 9,716 | Shares | Sole | 2023-04-14 | |
| 2022-12-31 | $1,260,878 | 14,687 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $901,414 | 14,612 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $912,377 | 14,761 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $840,444 | 14,137 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $890,924 | 12,270 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $841,203 | 12,043 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $830,382 | 12,059 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $2,394,606 | 37,051 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $2,077,726 | 35,663 | Shares | Sole | 2021-01-20 | |
| 2020-09-30 | $1,939,237 | 30,689 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $2,333,821 | 30,333 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $2,230,165 | 29,831 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||